Scott Gottlieb, President Donald Trump’s nominee to lead the Food and Drug Administration, cleared a key Senate hurdle Thursday and is on track for a confirmation vote in the coming days.
The Senate Health, Education, Labor and Pensions Committee voted 14-9 to approve Gottlieb’s nomination, sending it to a vote of the full Senate. Two Democrats, Sens. Sheldon Whitehouse of Rhode Island and Michael Bennet of Colorado, joined the committee’s 12 Republicans to endorse Gottlieb’s nomination.
Generally, nominees who receive bipartisan support by the committees overseeing their confirmation hearings receive little or no serious opposition when the full Senate convenes to vote.
Gottlieb, 44, a physician and health analyst, was the FDA’s deputy director under former President George W. Bush. He has been an outspoken advocate on behalf of large pharmaceutical companies and critic of federal regulations that hamper their ability to more quickly get drugs to market.
No date has been set for a full floor vote on Gottlieb’s confirmation.
Amazon sales growth slows as new CEO takes over
PG&E could face criminal charges over deadly California fire
The amount of Greenland ice that melted on Tuesday could cover Florida in 2 inches of water
Biden to allow eviction moratorium to expire Saturday
Kim stresses military preparations ahead of U.S.-South Korea drills
Europe6 days ago
French protesters reject bill requiring vaccine passes
Latin America7 days ago
Haitian president’s hometown holds funeral amid violence
Middle East6 days ago
Iran rejects UN rights chief’s ‘false accusations’ over water protests
North America6 days ago
Canada’s women aim to plant flag again in Olympic swimming despite pandemic
Europe6 days ago
Vatican reveals property holdings for first time in transparency drive
Health6 days ago
Potential Role of ‘Junk DNA’ Sequence in Aging, Cancer
Asia5 days ago
Volunteer collapses from heat at Tokyo Olympics
Latin America6 days ago
Russia sends COVID-19 aid to Cuba